Study: India has a long way to reach zero catastrophic costs goal for TB patients

A recent study led by Dr. Susmita Chatterjee from The George Institute of Global Health, India, has shed light on the long-term economic impact of TB on patients, even a year after the end of treatment. The study has also shown that India still has a long way to go to reach the goal of zero catastrophic costs for all patient groups, as stated in the END TB Strategy. As an outcome of the understanding, the scientists have recommended a few strategic solutions to reduce the catastrophic impacts of TB in India.

Researchers design a microfluidics physics-based device to predict cancer therapy response

One of the great challenges in the fight against cancer is to design new technologies for a personalized treatment for each patient. Depending on the molecular characteristics—DNA mutations for instance—of each tumor, precision medicine aims to make it easier for cancer patients, both adult and pediatric, to receive a personalized treatment that is appropriate to their pathology. But is it possible to know whether or not a patient can benefit from a treatment before starting therapy?

Researchers report that patients with rare type of astrocytoma, a neuron tumor, have worse prognosis than expected

A team of researchers from the Nagoya University Graduate School of Medicine has reported that patients with a rare form of brain and spinal cord cancer, localized isocitrate dehydrogenase wild-type (IDHwt) histologically diffuse astrocytoma, have a poor prognosis similar to the most malignant types of brain and spinal cord tumors. Their findings, published in the journal Scientific Reports, point to the need for strong postoperative care for patients with this type of tumor.